The FDA has previously approved the SGLT2 inhibitor in patients with HFrEF, but not HFmrEF or HFpEF

The draft update marks a shift from the task force's previous guidelines, which had endorsed screening beginning at age 50.

New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen in this important specialty. 

Imaging groups and pain-management associations urged Humana, Aetna and others to lift restrictions around procedures to treat compression fractures. 

A new Medical Group Management Association report details how the problematic policies are negatively impacting patient care.

News of the CDC director’s departure comes on the same day as an announcement made by the World Health Organization declaring the end of the COVID global health emergency.

The policy changes forbid insurers from saddling patients with out-of-pocket costs for services associated with lung and breast cancer.

The college believes the move will sow confusion and is asking the agency to rescind its noncoverage determination.